Literature DB >> 12451326

Prostaglandins are involved in acetylcholine- and 5-hydroxytryptamine-induced, nitric oxide-mediated vasodilatation in human forearm.

Adriaan M Kamper1, Leendert C Paul, Gerard J Blauw.   

Abstract

Both acetylcholine (ACh) and 5-hydroxytryptamine (5HT) are used to examine nitric oxide (NO)-mediated vasodilatation in humans. Animal data suggest that both substances can also induce the release of prostacyclin (PGI ). This study was designed to investigate the role of the prostaglandin pathway in Ach- and 5HT-induced vasodilation in humans. The experiments were done in three groups of healthy male volunteers. In group 1 (n = 6), ACh (100-1,000 ng/kg/min) and sodium-nitroprusside (10-100 ng/kg/min) were infused into the brachial artery alone, together with a continuous infusion of indomethacin (1.3 micro g/kg/min) and during a combined infusion of indomethacin and the competitive NO synthase inhibitor N -monomethyl-l-arginine (l-NMMA; 30 micro g/kg/min). In group 2 (n = 5), 5HT (0.3-1.0 ng/kg/min) was infused alone and together with a continuous infusion of indomethacin and l-NMMA. In group 3 (n = 6), the synthetic prostaglandin analog iloprost (0.5-4.5 ng/kg/min) was infused together with a continuous infusion of saline, l-NMMA, and l-NMMA with indomethacin, respectively. The infusions of indomethacin and l-NMMA started 10 min before the infusion of ACh, 5HT, iloprost, and sodium nitroprusside. Forearm blood flow was measured using computerized venous occlusion plethysmography. Both the Ach- and 5HT-induced vasodilator responses were significantly attenuated by indomethacin (p < 0.05 for both), but not further influenced by a concomitant infusion of l-NMMA. The vasodilatation induced by iloprost was significantly inhibited by l-NMMA (p < 0.05) and not affected by indomethacin. The sodium nitroprusside-induced vasodilation was influenced by neither l-NMMA nor indomethacin. It is concluded that in the human forearm, the prostaglandin pathway is involved in both the Ach- and 5HT-induced NO-mediated vasodilatation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12451326     DOI: 10.1097/00005344-200212000-00014

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  8 in total

1.  Endothelium-dependent vasodilatory signalling modulates α1 -adrenergic vasoconstriction in contracting skeletal muscle of humans.

Authors:  Christopher M Hearon; Brett S Kirby; Gary J Luckasen; Dennis G Larson; Frank A Dinenno
Journal:  J Physiol       Date:  2016-10-13       Impact factor: 5.182

2.  Phosphodiesterase type 5 inhibition does not reverse endothelial dysfunction in patients with coronary heart disease.

Authors:  S D Robinson; C A Ludlam; N A Boon; D E Newby
Journal:  Heart       Date:  2005-04-29       Impact factor: 5.994

3.  Prostaglandins do not contribute to the nitric oxide-mediated compensatory vasodilation in hypoperfused exercising muscle.

Authors:  Darren P Casey; Michael J Joyner
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-05-02       Impact factor: 4.733

4.  Roles of nitric oxide synthase and cyclooxygenase in leg vasodilation and oxygen consumption during prolonged low-intensity exercise in untrained humans.

Authors:  William G Schrage; Brad W Wilkins; Christopher P Johnson; John H Eisenach; Jacqueline K Limberg; Niki M Dietz; Timothy B Curry; Michael J Joyner
Journal:  J Appl Physiol (1985)       Date:  2010-06-17

5.  The function of vascular smooth muscle phosphodiesterase III is preserved in healthy human aging.

Authors:  Rachel L Elvebak; John H Eisenach; Michael J Joyner; Wayne T Nicholson
Journal:  Clin Transl Sci       Date:  2010-10       Impact factor: 4.689

6.  Effect of extraluminal ATP application on vascular tone and blood flow in skeletal muscle: implications for exercise hyperemia.

Authors:  Michael Nyberg; Baraa K Al-Khazraji; Stefan P Mortensen; Dwayne N Jackson; Christopher G Ellis; Ylva Hellsten
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-06-12       Impact factor: 3.619

7.  Aging is associated with reduced prostacyclin-mediated dilation in the human forearm.

Authors:  Wayne T Nicholson; Brianna Vaa; Christiane Hesse; John H Eisenach; Michael J Joyner
Journal:  Hypertension       Date:  2009-05-04       Impact factor: 10.190

8.  Endothelium-dependent NO-mediated vasodilation in humans is attenuated by peripheral alpa1-adrenoceptor activation.

Authors:  Adriaan M Kamper; Anton J M de Craen; Rudi G J Westendorp; Gerard J Blauw
Journal:  Vasc Health Risk Manag       Date:  2005
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.